Effect of recombinant SP-C surfactant in a porcine lavage model of acute lung injury

被引:36
|
作者
Spragg, RG
Smith, RM
Harris, K
Lewis, J
Häfner, D
Germann, P
机构
[1] Univ Calif San Diego, Dept Med, Sch Med, San Diego, CA 92161 USA
[2] San Diego Vet Affairs Hlth Care Syst, San Diego, CA 92161 USA
[3] Univ Western Ontario, Dept Med, Lawson Res Inst, St Josephs Hlth Ctr, London, ON N6A 5B8, Canada
[4] Byk Gulden, D-78467 Constance, Germany
关键词
pulmonary surfactant; surfactant apoprotein C; acute respiratory distress syndrome; phospholipids;
D O I
10.1152/jappl.2000.88.2.674
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Synthetic surfactants allow examination of the effects of specific components of natural surfactant. To determine whether surfactant containing apoprotein C, dipalmitoyl-phosphatidylcholine, phosphatidylglycerol, and palmitic acid restores gas-exchanging function in acute lung injury (ALI), we administered such surfactant tin doses of 50 or 100 mg/kg and in volumes from 1 to 6 ml/kg) or phospholipid (PL) alone, by intratracheal instillation, to pigs with ALI induced by massive saline lavage. Animals ventilated with 100% O-2 and receiving 1, 2, 4, or 6 ml/kg of 50 mg/kg recombinant surfactant apoprotein C: (rSP-C) surfactant or 2 ml/kg of 50 mg/kg PL (control) had mean arterial PO2 values, 4 h after treatment, of 230, 332, 130, 142, or 86 Torr, respectively. Animals receiving 1, 2, or 4 ml/kg of 100 mg/kg rSP-C surfactant or 2 ml/kg of 100 mg/kg PL (control) had mean arterial PO2 values of 197, 214, 148, or 88 Torr, respectively. Surfactant PL distribution was homogeneous. Hyaline membrane formation pp-as reduced in treated animals. Thus, in this model of ALI, rSP-C with PL has the capacity to improve gas exchange and possibly modify lung injury.
引用
收藏
页码:674 / 681
页数:8
相关论文
共 50 条
  • [32] CHARACTERIZATION OF SURFACTANT PROTEIN-C (SP-C)
    CREUWELS, LAJM
    DEMEL, RA
    VANGOLDE, LMG
    HAAGSMAN, HP
    PEDIATRIC RESEARCH, 1994, 36 (01) : A11 - A11
  • [33] EFFECTS OF LUNG SURFACTANT PROTEOLIPID SP-C ON THE ORGANIZATION OF MODEL MEMBRANE-LIPIDS - A FLUORESCENCE STUDY
    HOROWITZ, AD
    ELLEDGE, B
    WHITSETT, JA
    BAATZ, JE
    BIOCHIMICA ET BIOPHYSICA ACTA, 1992, 1107 (01) : 44 - 54
  • [34] Effect of hydrophobic protein SP-C on structure and dilatational properties of the model monolayers of pulmonary surfactant
    Panaiotov, I
    Ivanova, T
    Proust, J
    Boury, F
    Denizot, B
    Keough, K
    Taneva, S
    COLLOIDS AND SURFACES B-BIOINTERFACES, 1996, 6 (4-5) : 243 - 260
  • [35] Cholesterol modulates the exposure and orientation of pulmonary surfactant protein SP-C in model surfactant membranes
    Gomez-Gil, L.
    Perez-Gil, J.
    Goormaghtigh, E.
    BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES, 2009, 1788 (09): : 1907 - 1915
  • [36] SP-B, SP-C and membrane curvature: mediating cholesterol distribution in the lung surfactant system
    Roldan, N.
    Nyholm, T. K.
    Slotte, J. P.
    Perez-Gil, J.
    Garcia-Alvarez, B.
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2015, 44 : S197 - S197
  • [37] Expression of lung surfactant proteins SP-B and SP-C and their modulating factors in fetal lung of FGR rats
    Deng, Fei-tao
    Ouyang, Wei-xiang
    Ge, Liang-fang
    Zhang, Li
    Chai, Xin-qun
    JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2015, 35 (01) : 122 - 128
  • [38] Kinetics of phospholipid insertion into monolayers containing the lung surfactant proteins SP-B or SP-C
    Michaela Ross
    Silke Krol
    Andreas Janshoff
    Hans-Joachim Galla
    European Biophysics Journal, 2002, 31 : 52 - 61
  • [39] Effects of C1 inhibitor and r-SP-C surfactant on oxygenation and histology in rats with lavage-induced acute lung injury
    Burkhard Vangerow
    Dietrich Häfner
    Horst Rueckoldt
    Gernot Marx
    Nils Ott
    Martin Leuwer
    Ilka Frerking
    Paul G. Germann
    Intensive Care Medicine, 2001, 27 : 1526 - 1531
  • [40] Effects of C1 inhibitor and r-SP-C surfactant on oxygenation and histology in rats with lavage-induced acute lung injury
    Vangerow, B
    Häfner, D
    Rueckoldt, H
    Marx, G
    Ott, N
    Leuwer, M
    Frerking, I
    Germann, PG
    INTENSIVE CARE MEDICINE, 2001, 27 (09) : 1526 - 1531